• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新型氮杂环香豆素衍生物作为靶向烯酰基酰基载体蛋白还原酶(InhA)的抗菌剂的设计、合成及计算研究

Design, synthesis and computational studies of new azaheterocyclic coumarin derivatives as anti- agents targeting enoyl acyl carrier protein reductase (InhA).

作者信息

Batran Rasha Z, Sabt Ahmed, Dziadek Jarosław, Kassem Asmaa F

机构信息

Chemistry of Natural Compounds Department, Pharmaceutical and Drug Industries Research Institute, National Research Centre Dokki Cairo 12622 Egypt

Laboratory of Genetics and Physiology of Mycobacterium, Institute of Medical Biology of the Polish Academy of Sciences Lodz Poland.

出版信息

RSC Adv. 2024 Jul 9;14(30):21763-21777. doi: 10.1039/d4ra02746a. eCollection 2024 Jul 5.

DOI:10.1039/d4ra02746a
PMID:38984262
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11232110/
Abstract

In this study, we designed and synthesized a series of coumarin derivatives as antitubercular agents targeting the enoyl acyl carrier protein reductase (InhA) enzyme. Among the synthesized compounds, the tetrazole derivative 4c showed the most potent antitubercular effect with a minimum inhibitory concentration value (MIC) of 15 μg mL against H37Rv and could also inhibit the growth of the mutant strain (Δ). Compound 4c was able to penetrate -infected human macrophages and suppress the intracellular growth of tubercle bacilli. Moreover, the target derivative 4c showed a potent inhibitory effect against InhA enzyme with an IC value of 0.565 μM, which was superior to the reference InhA inhibitor triclosan. Molecular docking of compound 4c within the InhA active site revealed the importance of the 4-phenylcoumarin ring system and tetrazole moiety for activity. Finally, the physicochemical properties and pharmacokinetic parameters of 4c were investigated.

摘要

在本研究中,我们设计并合成了一系列香豆素衍生物作为靶向烯酰基载体蛋白还原酶(InhA)的抗结核药物。在合成的化合物中,四唑衍生物4c表现出最有效的抗结核作用,对H37Rv的最低抑菌浓度值(MIC)为15μg/mL,并且还能抑制突变菌株(Δ)的生长。化合物4c能够穿透受感染的人类巨噬细胞并抑制结核杆菌的细胞内生长。此外,目标衍生物4c对InhA酶表现出强效抑制作用,IC值为0.565μM,优于参考InhA抑制剂三氯生。化合物4c在InhA活性位点内的分子对接揭示了4-苯基香豆素环系统和四唑部分对活性的重要性。最后,研究了4c的物理化学性质和药代动力学参数。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2415/11232110/2ad4a3f2454a/d4ra02746a-f8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2415/11232110/e18f275fa791/d4ra02746a-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2415/11232110/633336c031d6/d4ra02746a-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2415/11232110/e4a90b5ea463/d4ra02746a-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2415/11232110/42331cc1d85e/d4ra02746a-s1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2415/11232110/eb516df0a820/d4ra02746a-s2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2415/11232110/5a1c41447645/d4ra02746a-s3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2415/11232110/aeeff5513b15/d4ra02746a-s4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2415/11232110/5b241e5b928c/d4ra02746a-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2415/11232110/59360fbb7c6b/d4ra02746a-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2415/11232110/0ca9cb404957/d4ra02746a-f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2415/11232110/9f540d54749a/d4ra02746a-f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2415/11232110/2ad4a3f2454a/d4ra02746a-f8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2415/11232110/e18f275fa791/d4ra02746a-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2415/11232110/633336c031d6/d4ra02746a-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2415/11232110/e4a90b5ea463/d4ra02746a-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2415/11232110/42331cc1d85e/d4ra02746a-s1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2415/11232110/eb516df0a820/d4ra02746a-s2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2415/11232110/5a1c41447645/d4ra02746a-s3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2415/11232110/aeeff5513b15/d4ra02746a-s4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2415/11232110/5b241e5b928c/d4ra02746a-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2415/11232110/59360fbb7c6b/d4ra02746a-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2415/11232110/0ca9cb404957/d4ra02746a-f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2415/11232110/9f540d54749a/d4ra02746a-f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2415/11232110/2ad4a3f2454a/d4ra02746a-f8.jpg

相似文献

1
Design, synthesis and computational studies of new azaheterocyclic coumarin derivatives as anti- agents targeting enoyl acyl carrier protein reductase (InhA).新型氮杂环香豆素衍生物作为靶向烯酰基酰基载体蛋白还原酶(InhA)的抗菌剂的设计、合成及计算研究
RSC Adv. 2024 Jul 9;14(30):21763-21777. doi: 10.1039/d4ra02746a. eCollection 2024 Jul 5.
2
New coumarin linked thiazole derivatives as antimycobacterial agents: Design, synthesis, enoyl acyl carrier protein reductase (InhA) inhibition and molecular modeling.新型香豆素连接噻唑衍生物作为抗分枝杆菌剂:设计、合成、烯酰基辅酶 A 还原酶(InhA)抑制和分子模拟。
Bioorg Chem. 2024 Sep;150:107511. doi: 10.1016/j.bioorg.2024.107511. Epub 2024 May 31.
3
Biological evaluation of potent triclosan-derived inhibitors of the enoyl-acyl carrier protein reductase InhA in drug-sensitive and drug-resistant strains of Mycobacterium tuberculosis.结核分枝杆菌药敏和耐药菌株中强效三氯生衍生的烯酰-酰基载体蛋白还原酶InhA抑制剂的生物学评价
ChemMedChem. 2014 Nov;9(11):2528-37. doi: 10.1002/cmdc.201402255. Epub 2014 Aug 27.
4
Design and synthesis of thiourea-based derivatives as Mycobacterium tuberculosis growth and enoyl acyl carrier protein reductase (InhA) inhibitors.基于硫脲的衍生物的设计与合成作为结核分枝杆菌生长和烯酰基辅酶 A 还原酶(InhA)抑制剂。
Eur J Med Chem. 2020 Aug 1;199:112402. doi: 10.1016/j.ejmech.2020.112402. Epub 2020 May 4.
5
Synthesis, Biological Evaluation and Molecular Docking Studies of New Pyrazolines as an Antitubercular and Cytotoxic Agents.新型吡唑啉类抗结核和细胞毒性药物的合成、生物学评价及分子对接研究
Infect Disord Drug Targets. 2019;19(3):310-321. doi: 10.2174/1871526519666181217120626.
6
Benzenesulfonohydrazide-tethered non-fused and fused heterocycles as potential anti-mycobacterial agents targeting enoyl acyl carrier protein reductase (InhA) with antibiofilm activity.作为潜在的抗分枝杆菌药物,苯磺酰肼连接的非稠合和稠合杂环靶向烯酰酰基载体蛋白还原酶(InhA)并具有抗生物膜活性。
RSC Adv. 2024 Sep 23;14(41):30165-30179. doi: 10.1039/d4ra05616g. eCollection 2024 Sep 18.
7
Anti-tubercular activity and molecular docking studies of indolizine derivatives targeting mycobacterial InhA enzyme.针对分枝杆菌 InhA 酶的吲嗪衍生物的抗结核活性和分子对接研究。
J Enzyme Inhib Med Chem. 2021 Dec;36(1):1472-1487. doi: 10.1080/14756366.2021.1919889.
8
Development of gallic acid formazans as novel enoyl acyl carrier protein reductase inhibitors for the treatment of tuberculosis.没食子酸甲臜作为新型烯酰基酰基载体蛋白还原酶抑制剂用于治疗结核病的研发。
Bioorg Med Chem Lett. 2017 Feb 15;27(4):808-815. doi: 10.1016/j.bmcl.2017.01.026. Epub 2017 Jan 11.
9
Identification of new anti-mycobacterial agents based on quinoline-isatin hybrids targeting enoyl acyl carrier protein reductase (InhA).基于靶向烯酰酰基载体蛋白还原酶(InhA)的喹啉-异吲哚酮杂化物鉴定新型抗分枝杆菌药物。
Bioorg Chem. 2024 Mar;144:107138. doi: 10.1016/j.bioorg.2024.107138. Epub 2024 Jan 20.
10
Design and synthesis of Thieno[3, 2-b]pyridinone derivatives exhibiting potent activities against Mycobacterium tuberculosis in vivo by targeting Enoyl-ACP reductase.设计并合成噻吩并[3,2-b]吡啶酮衍生物,通过靶向烯酰基辅酶 A 还原酶,在体内显示出对结核分枝杆菌的强大活性。
Eur J Med Chem. 2024 Dec 5;279:116806. doi: 10.1016/j.ejmech.2024.116806. Epub 2024 Aug 31.

引用本文的文献

1
Discovery of '-(1-(coumarin-3-yl)ethylidene)benzenesulfonohydrazide as a novel wound healing enhancer: synthesis, biological assessment, and molecular modeling.发现“-(1-(香豆素-3-基)亚乙基)苯磺酰肼”作为一种新型伤口愈合增强剂:合成、生物学评估及分子模拟
Front Chem. 2025 Aug 8;13:1621717. doi: 10.3389/fchem.2025.1621717. eCollection 2025.
2
Synthesis and anti-SARS-CoV-2 potential of novel coumarin hybrids: a combined wet/dry lab approach targeting M, Nsp15 and spike protein.新型香豆素杂化物的合成及其抗SARS-CoV-2潜力:一种针对M、Nsp15和刺突蛋白的湿/干实验室联合方法
RSC Adv. 2025 Jun 3;15(23):18577-18592. doi: 10.1039/d5ra02615f. eCollection 2025 May 29.
3

本文引用的文献

1
New pyrazolylindolin-2-one based coumarin derivatives as anti-melanoma agents: design, synthesis, dual BRAF/VEGFR-2 inhibition, and computational studies.新型基于吡唑并吲哚啉-2-酮的香豆素衍生物作为抗黑色素瘤药物:设计、合成、双重BRAF/VEGFR-2抑制及计算研究
RSC Adv. 2024 Feb 16;14(9):5907-5925. doi: 10.1039/d4ra00157e. eCollection 2024 Feb 14.
2
Identification of new anti-mycobacterial agents based on quinoline-isatin hybrids targeting enoyl acyl carrier protein reductase (InhA).基于靶向烯酰酰基载体蛋白还原酶(InhA)的喹啉-异吲哚酮杂化物鉴定新型抗分枝杆菌药物。
Bioorg Chem. 2024 Mar;144:107138. doi: 10.1016/j.bioorg.2024.107138. Epub 2024 Jan 20.
3
Coumarin hybrids: dual-target candidates for future antimicrobial and antitubercular therapies.
香豆素杂合物:未来抗菌和抗结核治疗的双靶点候选物。
Future Med Chem. 2025 May;17(10):1131-1142. doi: 10.1080/17568919.2025.2504331. Epub 2025 May 12.
4
Design and synthesis of PDSPTCF as an influential Brønsted-Lewis acidic catalyst for the producing benzo[a]benzo[6,7]chromeno[2,3-c]phenazines.作为一种用于生产苯并[a]苯并[6,7]色烯并[2,3-c]吩嗪的有影响力的布朗斯特-路易斯酸性催化剂的PDSPTCF的设计与合成。
Sci Rep. 2024 Dec 2;14(1):29907. doi: 10.1038/s41598-024-78824-2.
4-Phenylcoumarin derivatives as new HIV-1 NNRTIs: Design, synthesis, biological activities, and computational studies.
4-苯基香豆素衍生物作为新型 HIV-1 NNRTIs 的设计、合成、生物活性及计算研究
Bioorg Chem. 2023 Dec;141:106918. doi: 10.1016/j.bioorg.2023.106918. Epub 2023 Oct 14.
4
EGFR and PI3K/m-TOR inhibitors: design, microwave assisted synthesis and anticancer activity of thiazole-coumarin hybrids.表皮生长因子受体(EGFR)和磷脂酰肌醇-3-激酶/哺乳动物雷帕霉素靶蛋白(PI3K/m-TOR)抑制剂:噻唑-香豆素杂化物的设计、微波辅助合成及抗癌活性
RSC Adv. 2023 Oct 4;13(42):29070-29085. doi: 10.1039/d3ra03483f.
5
Discovery of new diaryl ether inhibitors against Mycobacterium tuberculosis targeting the minor portal of InhA.发现针对分枝杆菌的 InhA 小门户的新型二芳基醚抑制剂。
Eur J Med Chem. 2023 Nov 5;259:115646. doi: 10.1016/j.ejmech.2023.115646. Epub 2023 Jul 16.
6
Synthesis, Characterization, Antitubercular Activity, and Molecular Docking Studies of Pyrazolylpyrazoline-Clubbed Triazole and Tetrazole Hybrids.吡唑基吡唑啉结合的三唑和四唑杂化物的合成、表征、抗结核活性及分子对接研究
ACS Omega. 2023 Jun 2;8(23):20262-20271. doi: 10.1021/acsomega.2c07267. eCollection 2023 Jun 13.
7
Isatin-pyrimidine hybrid derivatives as enoyl acyl carrier protein reductase (InhA) inhibitors against Mycobacterium tuberculosis.异吲哚酮-嘧啶杂合衍生物作为抗结核分枝杆菌的烯酰基酰基载体蛋白还原酶(InhA)抑制剂
Bioorg Chem. 2023 Sep;138:106591. doi: 10.1016/j.bioorg.2023.106591. Epub 2023 May 6.
8
Recent Advances in Anti-Tuberculosis Drug Discovery Based on Hydrazide-Hydrazone and Thiadiazole Derivatives Targeting InhA.基于酰肼-腙和噻二唑衍生物靶向InhA的抗结核药物发现的最新进展
Pharmaceuticals (Basel). 2023 Mar 23;16(4):484. doi: 10.3390/ph16040484.
9
WHO's Global Tuberculosis Report 2022.世界卫生组织《2022年全球结核病报告》。
Lancet Microbe. 2023 Jan;4(1):e20. doi: 10.1016/S2666-5247(22)00359-7. Epub 2022 Dec 12.
10
2,4-Disubstituted pyridine derivatives are effective against intracellular and biofilm-forming tubercle bacilli.2,4-二取代吡啶衍生物对细胞内和形成生物膜的结核杆菌有效。
Front Pharmacol. 2022 Nov 10;13:1004632. doi: 10.3389/fphar.2022.1004632. eCollection 2022.